Graves' Ophthalmopathy

Overview

Journal N Engl J Med

Specialty General Medicine

Date 2010 Feb 26

PMID 20181974

Citations 615

Authors

Rebecca S Bahn

Affiliations

Soon will be listed here.

Citing Articles

Complement C5/C5a in the diagnosis and treatment of Graves ophthalmopathy: A Mendelian randomized study.

Zhu M, Wu B, Chen-Zhao C, Chen H, Xiong W Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025; 49(10):1633-1641.

PMID: 40074312 PMC: 11897966. DOI: 10.11817/j.issn.1672-7347.2024.240062.

Acute Pericarditis Associated With Graves' Disease: A Case Report.

Estrela Santos M, Baptista M, Reis J, Moura R, Resende J Cureus. 2025; 17(2):e78588.

PMID: 40062048 PMC: 11888993. DOI: 10.7759/cureus.78588.

PDK2-enhanced glycolysis aggravates fibrosis via IL11 signaling pathway in Graves' orbitopathy.

Peng Z, Huang R, Gan L, Wang J, Li X, Ding J Front Immunol. 2025; 16:1537365.

PMID: 40018034 PMC: 11865214. DOI: 10.3389/fimmu.2025.1537365.

Eyeball descending identification using MRI-based spatial coordinates in thyroid-associated orbitopathy patients with unilateral upper eyelid retraction.

Gou X, Wang Y, Li T, Zhou L, Lian J, Zhang X Quant Imaging Med Surg. 2025; 15(2):1287-1296.

PMID: 39995720 PMC: 11847195. DOI: 10.21037/qims-24-1659.

Dysthyroid optic neuropathy treated with tocilizumab.

Yan Y, Cai Z, Ren M, Li X, Yang R, Huang C Endocrinol Diabetes Metab Case Rep. 2025; 2025(1).

PMID: 39986262 PMC: 11883860. DOI: 10.1530/EDM-24-0045.

References

Smolen J, Beaulieu A, Rubbert-Roth A, Ramos-Remus C, Rovensky J, Alecock E . Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet. 2008; 371(9617):987-97. DOI: 10.1016/S0140-6736(08)60453-5. View

Feldon S, OLoughlin C, Ray D, Landskroner-Eiger S, Seweryniak K, Phipps R . Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes. Am J Pathol. 2006; 169(4):1183-93. PMC: 1698858. DOI: 10.2353/ajpath.2006.060434. View

Misharin A, Nagayama Y, Aliesky H, Mizutori Y, Rapoport B, McLachlan S . Attenuation of induced hyperthyroidism in mice by pretreatment with thyrotropin receptor protein: deviation of thyroid-stimulating to nonfunctional antibodies. Endocrinology. 2009; 150(8):3944-52. PMC: 2717879. DOI: 10.1210/en.2009-0181. View

Smith T, Koumas L, Gagnon A, Bell A, Sempowski G, Phipps R . Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab. 2002; 87(1):385-92. DOI: 10.1210/jcem.87.1.8164. View

Crisp M, Lane C, Halliwell M, Wynford-Thomas D, Ludgate M . Thyrotropin receptor transcripts in human adipose tissue. J Clin Endocrinol Metab. 1997; 82(6):2003-5. View

Tan G, Dutton C, Bahn R . Interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptor inhibit IL-1-induced glycosaminoglycan production in cultured human orbital fibroblasts from patients with Graves' ophthalmopathy. J Clin Endocrinol Metab. 1996; 81(2):449-52. DOI: 10.1210/jcem.81.2.8636247. View

Hiromatsu Y, Yang D, Bednarczuk T, Miyake I, Nonaka K, Inoue Y . Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy. J Clin Endocrinol Metab. 2000; 85(3):1194-9. DOI: 10.1210/jcem.85.3.6433. View

Heufelder A, Dutton C, Sarkar G, Donovan K, Bahn R . Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy. Thyroid. 1993; 3(4):297-300. DOI: 10.1089/thy.1993.3.297. View

Baker G, Mazziotti G, von Ruhland C, Ludgate M . Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy. Endocrinology. 2004; 146(2):835-44. DOI: 10.1210/en.2004-1015. View

10.

Eckstein A, Losch C, Glowacka D, Schott M, Mann K, Esser J . Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy. Br J Ophthalmol. 2009; 93(8):1052-6. DOI: 10.1136/bjo.2007.137265. View

11.

Sempowski G, ROZENBLIT J, Smith T, Phipps R . Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production. Am J Physiol. 1998; 274(3):C707-14. DOI: 10.1152/ajpcell.1998.274.3.C707. View

12.

Otto E, Ochs K, Hansen C, Wall J, Kahaly G . Orbital tissue-derived T lymphocytes from patients with Graves' ophthalmopathy recognize autologous orbital antigens. J Clin Endocrinol Metab. 1996; 81(8):3045-50. DOI: 10.1210/jcem.81.8.8768872. View

13.

Dutton C, Joba W, Spitzweg C, Heufelder A, Bahn R . Thyrotropin receptor expression in adrenal, kidney, and thymus. Thyroid. 1998; 7(6):879-84. DOI: 10.1089/thy.1997.7.879. View

14.

Pritchard J, Han R, Horst N, Cruikshank W, Smith T . Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway. J Immunol. 2003; 170(12):6348-54. DOI: 10.4049/jimmunol.170.12.6348. View

15.

Zhang L, Bowen T, Grennan-Jones F, Paddon C, Giles P, Webber J . Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction. J Biol Chem. 2009; 284(39):26447-55. PMC: 2785333. DOI: 10.1074/jbc.M109.003616. View

16.

Chan L, Tan H, Fook-Chong S, Teo T, Lim L, Seah L . Graves ophthalmopathy: the bony orbit in optic neuropathy, its apical angular capacity, and impact on prediction of risk. AJNR Am J Neuroradiol. 2009; 30(3):597-602. PMC: 7051464. DOI: 10.3174/ajnr.A1413. View

17.

Rapoport B, McLachlan S . The thyrotropin receptor in Graves' disease. Thyroid. 2007; 17(10):911-22. DOI: 10.1089/thy.2007.0170. View

18.

Salvi M, Vannucchi G, Campi I, Curro N, Dazzi D, Simonetta S . Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. Eur J Endocrinol. 2007; 156(1):33-40. DOI: 10.1530/eje.1.02325. View

19.

Konuk E, Konuk O, Misirlioglu M, Menevse A, Unal M . Expression of cyclooxygenase-2 in orbital fibroadipose connective tissues of Graves' ophthalmopathy patients. Eur J Endocrinol. 2006; 155(5):681-5. DOI: 10.1530/eje.1.02280. View

20.

Smith T, Hoa N . Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor. J Clin Endocrinol Metab. 2004; 89(10):5076-80. DOI: 10.1210/jc.2004-0716. View